Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04784689 · ClinicalTrials.gov registry record
Host Immune Response to Novel RNA COVID-19 Vaccination
A clinical trial, sponsored by The University of Texas Health Science Center at San Antonio.
- Completed
- Registry status
- 50
- Enrollment target
NCT04784689 is a clinical trial that has completed, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 50 participants.
The verdict
NCT04784689 has completed, sponsored by The University of Texas Health Science Center at San Antonio.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
To determine the antibody response level in patients with cancer to the COVID-19 vaccination.
Interventions
- BIOLOGICAL COVID-19 Vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2021-02-24 |
| Est. Completion | 2022-05-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04784689
The ClinicalTrials.gov registry entry for NCT04784689 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center at San Antonio, which has 378 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which COVID-19 Vaccine is the first listed.
NCT04784689 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04784689 about?
NCT04784689 is a clinical study titled "Host Immune Response to Novel RNA COVID-19 Vaccination". To determine the antibody response level in patients with cancer to the COVID-19 vaccination.
What is the current status of trial NCT04784689?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2021-02-24. Estimated completion is 2022-05-18.
What interventions are being tested in trial NCT04784689?
The interventions under investigation include: COVID-19 Vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT04784689?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.